4Filed Mar 12, 8:00 PM ET

ACM Research (ACMR) CFO Mark McKechnie Exercises Options, Sells Shares

$ACMR · ACM Research, Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

ACM Research (ACMR) CFO Mark McKechnie Exercises Options, Sells Shares

What Happened
Mark McKechnie, Chief Financial Officer and Treasurer of ACM Research (ACMR), exercised a total of 98,551 option-derived shares (two exercises) and concurrently sold 98,551 shares in open-market transactions on March 12, 2026. He paid $1,584,759 to exercise the options (60,000 shares @ $13.89 = $833,400; 38,551 shares @ $19.49 = $751,359) and received aggregate gross proceeds of about $4.49 million from multiple weighted-average sales (total sales proceeds ≈ $4,491,952). The exercises are reported as fully vested and exercisable.

Key Details

  • Transaction date: March 12, 2026 (Form 4 filed March 13, 2026). Filing appears timely.
  • Option exercises (code M): 60,000 shares exercised @ $13.89 (cost $833,400); 38,551 shares exercised @ $19.49 (cost $751,359). Footnote F8: options fully vested and exercisable.
  • Open-market sales (code S): total 98,551 shares sold for combined proceeds ≈ $4,491,952 across multiple trades with weighted-average prices reported; individual sale blocks and weighted prices:
    • 11,910 shares @ $44.89 (≈ $534,640) — prices ranged $44.37–$45.35 (F2/F5)
    • 47,108 shares @ $45.74 (≈ $2,154,720) — ranges $45.37–$46.36 (F3) / $45.40–$46.39 (F6)
    • 982 shares @ $46.55 (≈ $45,712) — range $46.39–$46.59 (F4)
    • 8,639 shares @ $44.94 (≈ $388,237) — range $44.40–$45.39 (F5)
    • 29,348 shares @ $45.74 (≈ $1,342,378) — ranges noted above (F3/F6)
    • 564 shares @ $46.57 (≈ $26,265) — range $46.45–$46.59 (F7)
  • The filing includes derivative disposition entries at $0 for the same 60,000 and 38,551-share blocks, reflecting conversion/exercise of derivatives into shares prior to sale.
  • Trading plan: sales were made pursuant to a Rule 10b5‑1 trading plan adopted August 27, 2025 (F1).
  • Shares owned after the transactions: not specified in the data you provided (noted as “not reported” here).

Context
These entries show an exercise of vested options followed by immediate or near-immediate open-market sales under a pre-established 10b5‑1 plan (effectively a cashless exercise/sale pattern). Such transactions often reflect option-exercise and liquidity management rather than an independent investment view; they are factual disclosures of insider activity, not commentary on company prospects.